This study suggests that BC cells cultured on ECM, particularly COL1, exhibit increased chemoresistance due to the upregulation of ITGB1, which, in turn, leads to the increased expression and activity of ABC transporters, resulting in higher drug efflux and reduced intracellular drug levels [10]. The gene discussed is ABCG2; the disease is breast cancer.